Innovation1 Biotech Inc. (IVBT)

Overview

Innovation1 Biotech Inc., a company with a foundational base in Somerville, Massachusetts, established in 2014, originally embarked on a journey within the pharmaceutical industry with a focus on the development of modified schedule 1 molecules derived from botanical sources. However, as of the current state, Innovation1 Biotech Inc. reports that it does not have significant ongoing operations. This shift signifies a pivot or transition phase, with the company possibly exploring new directions beyond its initial focus on botanical origin molecules in the United States.

Products and Services

Previously, Innovation1 Biotech Inc. was engaged in the development of specific products and services, notably:

• Modified Schedule 1 Molecules: The core of their initial operations focused on researching and developing modified molecules from Schedule 1 substances. Schedule 1 drugs are classified by the DEA as substances with no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. Innovation1 Biotech's work in this area involved altering these molecules to potentially unlock therapeutic values for medical use, particularly those of botanical origin.